Effects of TCF7L2 polymorphisms on obesity in European populations (Q42817386)

7 November 2017

Effects of TCF7L2 polymorphisms on obesity in European populations (English)

1 reference

7 November 2017

0 references

10

1 reference

7 November 2017

12

1 reference

7 November 2017

17

1 reference

7 November 2017

Hélène Choquet

2

0 references

Thorkild I.A. Sørensen

14

object named as

Thorkild I A Sørensen

1 reference

7 November 2017

16

David Meyre

1 reference

7 November 2017

Stéphane Cauchi

1

1 reference

7 November 2017

Ruth Gutiérrez-Aguilar

3

1 reference

7 November 2017

Frédéric Capel

4

1 reference

7 November 2017

Katrine Grau

5

1 reference

7 November 2017

Christine Proença

6

1 reference

7 November 2017

Christian Dina

7

1 reference

7 November 2017

Alex Duval

8

1 reference

7 November 2017

Beverley Balkau

9

1 reference

7 November 2017

Natascha Potoczna

11

1 reference

7 November 2017

Fritz Horber

13

1 reference

7 November 2017

Guillaume Charpentier

15

1 reference

7 November 2017

1 February 2008

1 reference

7 November 2017

1 reference

7 November 2017

16

1 reference

7 November 2017

2

1 reference

7 November 2017

476-482

1 reference

Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes

7 November 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

TCF7L2 variation predicts hyperglycemia incidence in a French general population: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

Variants of the TCF7L2 gene are associated with beta cell dysfunction and confer an increased risk of type 2 diabetes mellitus in the ULSAM cohort of Swedish elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

Transcription factor 7-like 2 (TCF7L2) is associated with gestational diabetes mellitus and interacts with adiposity to alter insulin secretion in Mexican Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

A fat attack occurred in fat city

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

Inhibition of adipogenesis by Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

Tumour necrosis factor-alpha inhibits adipogenesis via a beta-catenin/TCF4(TCF7L2)-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

Function of GATA transcription factors in preadipocyte-adipocyte transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

Interaction between GATA and the C/EBP family of transcription factors is critical in GATA-mediated suppression of adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

A genome-wide association study identifies novel risk loci for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

Whole-genome patterns of common DNA variation in three human populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

Randomized, multi-center trial of two hypo-energetic diets in obese subjects: high- versus low-fat content

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

On estimating the relation between blood group and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

Transcription Factor TCF7L2 Genetic Study in the French Population: Expression in Human -Cells and Adipose Tissue and Strong Association With Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

ACDC/Adiponectin Polymorphisms Are Associated With Severe Childhood and Adult Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

Dietary carbohydrate modification induces alterations in gene expression in abdominal subcutaneous adipose tissue in persons with the metabolic syndrome: the FUNGENUT Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

Heterogeneous effect of peroxisome proliferator-activated receptor gamma2 Ala12 variant on type 2 diabetes risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

Genetic variants and common diseases--better late than never

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbean men and women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.77

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2007.77

1 reference

7 November 2017

1 reference